1887

Abstract

The immune responses of cattle inoculated with either a virulent or an attenuated vaccine strain of rinderpest virus (RPV) were examined by measuring the proliferation of peripheral blood mononuclear cells (PBMC) to whole RPV antigen preparations and to individual RPV major structural proteins expressed using recombinant adenoviruses. Responses to the T cell mitogen concanavalin A (ConA) were also measured as a control to monitor non-specific effects of infection with RPV on T cell responses. Infection with the vaccine strain of RPV was found to induce a strong CD4 T cell response. A specific response was detected to all RPV proteins tested, namely the haemagglutinin (H), fusion (F), nucleocapsid (N) and matrix (M) proteins, in animals vaccinated with the attenuated strain of the virus. No one protein was found to be dominant with respect to the induction of T cell proliferative responses. As expected, vaccination of cattle with an unrelated virus vaccine, a capripox vaccine, failed to produce a response to RPV antigens. While profound suppression of T cell responses was observed following infection with the virulent strain of RPV, no evidence of impairment of T cell responsiveness was observed following RPV vaccination, or on subsequent challenge of vaccinated animals with virulent virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-9-2137
2000-09-01
2020-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/9/0812137a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-9-2137&mimeType=html&fmt=ahah

References

  1. Anderson J., Barrett T., Scott G. R.. 1996; Manual on the Diagnosis of Rinderpest , 2nd edn. Rome: Food and Agriculture Organization of the United Nations;
    [Google Scholar]
  2. Baron M. D., Barrett T.. 1995; Sequencing and analysis of the nucleocapsid (N) and polymerase (L) genes and the terminal extragenic domains of the vaccine strain of rinderpest virus. Journal of General Virology76:93–602
    [Google Scholar]
  3. Baron M. D., Shaila M. S., Barrett T.. 1993; Cloning and sequence analysis of the phosphoprotein gene of rinderpest virus. Journal of General Virology74:299–304
    [Google Scholar]
  4. Baron M. D., Goatley L., Barrett T.. 1994; Cloning and sequence analysis of the matrix (M) protein gene of rinderpest virus and evidence for another bovine morbillivirus. Virology200:121–129
    [Google Scholar]
  5. Barrett T.. 1999; Rinderpest and distemper viruses. In Encyclopaedia of Virology pp1559–1668 Edited by Webster R. G., Granoff A.. London: Academic Press;
    [Google Scholar]
  6. Barrett T., Rossiter P.. 1999; Rinderpest: the disease and its impact on humans and animals. Advances in Virus Research54:89–110
    [Google Scholar]
  7. Bellini W. J., McFarlin D. E., Silver G. D., Mingioli E. S., McFarland H. F.. 1981; Immune reactivity of the purified hemagglutinin of measles virus. Infection and Immunity32:1051–1057
    [Google Scholar]
  8. Belsham G. J., Anderson E. C., Murray P. K., Anderson J., Barrett T.. 1989; Immune response and protection of cattle and pigs generated by a vaccinia recombinant expressing the F protein of rinderpest virus. Veterinary Record124:655–658
    [Google Scholar]
  9. Bensaid A., Hadam M.. 1991; Bovine CD4 (BoCD4). Veterinary Immunology and Immunopathology27:51–54
    [Google Scholar]
  10. Brown C. C., Torres A.. 1994; Distribution of antigen in cattle infected with rinderpest virus. Veterinary Pathology31:194–200
    [Google Scholar]
  11. Clevers H., MacHugh N. D., Bansaid A., Dunlap S., Baldwin C. L., Kaushal A., Lams K., Howard C. J., Morrison W. I.. 1990; Identification of a bovine surface antigen uniquely expressed on CD4 CD8 T cell receptor γ/δ+ T lymphocytes. European Journal of Immunology20:809–817
    [Google Scholar]
  12. Coovadia H. M., Parent M. A., Loening W. E., Wesley A., Burgess B., Hallett F., Brain P., Grace J., Naidoo J., Smythe P. M., Vos G. H.. 1974; An evaluation of factors associated with the depression of immunity in malnutrition and in measles. American Journal of Clinical Nutrition27:665–669
    [Google Scholar]
  13. Crespi M., Struthers J. K., Smith A. N., Lyons S. F.. 1988; Interferon status after measles virus infection. South African Medical Journal73:711–712
    [Google Scholar]
  14. Dagan R., Phillip M., Sarov I., Skibin A., Epstein S., Kuperman O.. 1987; Cellular immunity and T-lymphocyte subsets in young children with acute measles. Journal of Medical Virology22:175–182
    [Google Scholar]
  15. Evans S. A., Baron M. D., Chamberlain R. W., Goatley L., Barrett T.. 1994; Nucleotide sequence comparisons of the fusion protein gene from virulent and attenuated strains of rinderpest virus. Journal of General Virology75:3611–3617
    [Google Scholar]
  16. Fujinami R. S., Sun X., Howell J. M., Jenkin J. C., Burns J. B.. 1998; Modulation of immune system function by measles virus infection: role of soluble factor and direct infection. Journal of Virology72:9421–9427
    [Google Scholar]
  17. Gans H. A., Maldonado Y., Yasukawa L. L., Beeler J., Audet S., Rinki M. M., DeHovitz R., Arvin A. M.. 1999; IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. Journal of Immunology162:5569–5575
    [Google Scholar]
  18. Griffin D. E., Ward B. J.. 1993; Differential CD4 T cell activation in measles. Journal of Infectious Diseases168:275–281
    [Google Scholar]
  19. Griffin D. E., Ward B. J., Juaregui E., Johnson R. T., Vaisberg A.. 1992; Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. Journal of Infectious Diseases166:1170–1173
    [Google Scholar]
  20. Hickman C. J., Khan A. S., Rota P. A., Bellini W. J.. 1997; Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology235:386–397
    [Google Scholar]
  21. Hirsch R. L., Griffin D. E., Johnson R. T., Cooper S. J., Lindo de Soriano I., Roedenbeck S., Vaisberg A.. 1984; Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clinical Immunology and Immunopathology31:1–12
    [Google Scholar]
  22. Ilonen J., Makela M. J., Ziola B., Salmi A. A.. 1990; Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clinical and Experimental Immunology81:212–217
    [Google Scholar]
  23. Jeggo M. H., Wardley R. C., Corteyn A. H.. 1987; A reassessment of the dual vaccine against rinderpest and contagious bovine pleuropneumonia. Veterinary Record120:131–135
    [Google Scholar]
  24. Karp C. K., Wysocka M., Wahl L. M., Ahearn J. M., Cuomo P. J., Sherry B., Trinchieri G., Griffin D. E.. 1996; Mechanism of suppression of cell-mediated immunity by measles virus. Science273:228–231
    [Google Scholar]
  25. Kobune F., Sakata H., Sugiyama M., Sugiura A.. 1991; B95a, a marmoset lymphoblastoid cell line as a sensitive host for rinderpest virus. Journal of General Virology72:687–692
    [Google Scholar]
  26. McChesney M. B., Oldstone M. B.. 1989; Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Advances in Immunology45:335–380
    [Google Scholar]
  27. McChesney M. B., Kehrl J. H., Valsamakis A., Facuci A. S., Oldstone M. B. A.. 1987; Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. Journal of . Virology61:3441–3447
    [Google Scholar]
  28. McChesney M. B., Altman A., Oldstone M. B.. 1988; Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. Journal of Immunology140:1269–1273
    [Google Scholar]
  29. McChesney M. B., Fujinami R. S., Lerche N. W., Marx P. A., Oldstone M. B.. 1989; Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. Journal of Infectious Diseases159:757–760
    [Google Scholar]
  30. McGrory W. J., Bautista D. S., Graham F. L.. 1988; A simple technique for the rescue of early region mutations into infectious human adenovirus type 5. Virology163:614–617
    [Google Scholar]
  31. MacHugh N. D., Sopp P.. 1991; Bovine CD8 (BoCD8). Veterinary Immunology and Immunopathology27:65–70
    [Google Scholar]
  32. Muller C. P., Handtmann D., Brons N. H., Weinmann M., Wiesmuller K. H., Spahn G., Wiesneth M., Schneider F., Jung G.. 1993; Analysis of antibody response to the measles virus using synthetic peptides of the fusion protein. Evidence of non-random pairing of T and B cell epitopes. Virus Research30:271–280
    [Google Scholar]
  33. Naessens J., Sileghem M., MacHugh N., Park Y. H., Davis W. C., Toye P.. 1992; Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene. Immunology76:305–309
    [Google Scholar]
  34. Ohishi K., Inui K., Yamanouchi K., Barrett T.. 1999a; Cell-mediated immune responses in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid protein of rinderpest virus. Journal of General Virology80:1627–1634
    [Google Scholar]
  35. Ohishi K., Kamata H., Yamanouchi K., Barrett T.. 1999b; Identification of T-helper epitopes in the hypervariable region of the nucleocapsid (N) protein of rinderpest virus (RPV) in cattle. Vaccine (in press)
    [Google Scholar]
  36. Pala S., Crimaldi G., Consolini R., Macchia P.. 1998; The cell-mediated response after measles vaccination. (In Italian.)Pediatrica Medica e Chirurgica20213–216
    [Google Scholar]
  37. Pette M., Liebert U. G., Gobel U., Grosse-Wilde H., Hartung H. P., Toyka K. V.. 1993; Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals. Neurology43:2019–2025
    [Google Scholar]
  38. Plowright W., Ferris R. D.. 1962; Studies with rinderpest virus in tissue culture. The use of attenuated culture virus as a vaccine for cattle. Research in Veterinary Science3:172–182
    [Google Scholar]
  39. Reed L. J., Muench H.. 1938; A simple method for estimating 50% endpoints. American Journal of Hygiene27:493–497
    [Google Scholar]
  40. Romero C. H., Barrett T., Chamberlain R. W., Kitching R. P., Fleming M., Black D. N.. 1994a; Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: Protection of cattle against rinderpest and lumpy skin disease viruses. Virology204:425–429
    [Google Scholar]
  41. Romero C. H., Barrett T., Kitching R. P., Carn V. M., Black D. N.. 1994b; Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Veterinary Record135:152–154
    [Google Scholar]
  42. Rose J. W., Bellini W. J., McFarlin D. E., McFarland H. F.. 1984; Human cellular immune response to measles virus polypeptides. Journal of Virology49:988–991
    [Google Scholar]
  43. Rossiter P. B., Herniman K. A. J., Gumm I. D., Morrison W. I.. 1993; The growth of cell culture-attenuated rinderpest virus in bovine lymphoblasts with B cell, CD4+ and CD8+ alpha/beta T cell and gamma/delta T cell phenotypes. Journal of General Virology74:305–309
    [Google Scholar]
  44. Schlender J., Schnorr J.-J., Spielhoffer P., Cathomen T., Cattaneo R., Billeter M. A., ter Meulen V., Schneider-Schaulies S.. 1996; Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro . Proceedings of the National Academy of Sciences, USA93:13194–13199
    [Google Scholar]
  45. Schnorr J.-J., Seufert M., Schlender J., Borst J., Johnston I. C. D., ter Meulen V., Schneider-Schaulies S.. 1997; Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro . Journal of General Virology78:3217–3226
    [Google Scholar]
  46. Scott G. R.. 1990; Rinderpest virus. In Viral Infections of Ruminants . pp341–354 Edited by Dinter Z., Morein B.. Amsterdam: Elsevier Science Publishers;
  47. Smedman L., Joki A., da Silva A. P., Troye-Blomberg M., Aronsson B., Perlmann P.. 1994; Immunosuppression after measles vaccination. Acta Paediatrica83:164–168
    [Google Scholar]
  48. Starr S., Berkovich S.. 1964; Effects of measles, gamma-globulin-modified measles and vaccine measles on the tuberculin test. New England Journal of Medicine270:386–391
    [Google Scholar]
  49. Stevenson P., Rossiter P. B., Munga L., Ndung’u E. K., Dolan R. B.. 1999; Rinderpest vaccination and the incidence and development of trypanosomosis in cattle. Tropical Animal Health and Production31:65–73
    [Google Scholar]
  50. Sun X., Burns J. B., Howell J. M., Fujinami R. S.. 1998; Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology246:24–33
    [Google Scholar]
  51. Tamashiro V. G., Perez H. H., Griffin D. E.. 1987; Prospective study of the magnitude and duration of changes in tuberculin reactivity during complicated and uncomplicated measles. Pediatric Infectious Disease Journal6:451–454
    [Google Scholar]
  52. Taylor W. P.. 1986; Epidemiology and control of rinderpest. Revue Scientifique et Technique de l’Office International des Epizooties5:407–410
    [Google Scholar]
  53. Ward B. J., Griffin D. E.. 1993; Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clinical Immunology and Immunopathology67:171–177
    [Google Scholar]
  54. Ward B. J., Johnson R. T., Vaisberg A., Jauregui E., Griffin D. E.. 1991; Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clinical Immunology and Immunopathology61:236–248
    [Google Scholar]
  55. Wesley A., Coovadia H. M., Henderson L.. 1978; Immunological recovery after measles. Clinical and Experimental Immunology32:540–544
    [Google Scholar]
  56. Whittle H. C., Dossetor J., Oduloju A., Bryceson A. D., Greenwood B. M.. 1978; Cell-mediated immunity during natural measles infection. Journal of Clinical Investigation62:678–684
    [Google Scholar]
  57. Wilkinson G. W. G., Akrigg A.. 1992; Constitutive and enhanced expression from the CMV major IE promotor in a defective adenovirus vector. Nucleic Acids Research20:2233–2239
    [Google Scholar]
  58. Wohlsein P., Trautwein G., Harder T. C., Liess B., Barrett T.. 1993; Viral antigen distribution in organs of cattle experimentally infected with rinderpest virus. Veterinary Pathology30:544–554
    [Google Scholar]
  59. Wohlsein P., Wamwayi H. M., Trautwein G., Pohlenz J., Liess B., Barrett T.. 1995; Pathomorphological and immunohistological findings in cattle experimentally infected with rinderpest virus isolates of different pathogenicity. Veterinary Microbiology44:141–147
    [Google Scholar]
  60. Yamanouchi K., Inui K., Sugimoto M., Asano F., Nishimaki F., Kitching R. P., Takamatsu H., Barrett T.. 1993; Immunisation of cattle with a recombinant vaccinia vector expressing the haemagglutinin gene of rinderpest virus. Veterinary Record132:152–156
    [Google Scholar]
  61. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B.. 1988; Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science242:1058–1061
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-9-2137
Loading
/content/journal/jgv/10.1099/0022-1317-81-9-2137
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error